The breast cancer diagnostics market is projected to be $2B worldwide and $800M in the U.S. by 2022.
CHICAGO (PRWEB) January 15, 2020
Ocean Tomo Transactions, LLC will auction a portfolio of 12 assets including six patents, five trademarks and 510 (k) FDA approval for breast cancer detection technology. This breast cancer detection technology in auction lot 103 utilizes military-grade thermal imaging to predict the likelihood of breast cancer. As a medical device opportunity that benefits from 8-year R&D and $18-million investment, the assets are advanced in different aspects. First, the assets support thermal imaging methodology to detect breast cancer at a very low cost and without radiation or painful procedure like a mammogram. Second, the analysis of the diagnostic tests utilizes a data analysis program that eliminates human error and improves the sensitivity of detecting the position of potential cancer in the breast.
The invention's potential impact to save lives is huge as well with early detection, especially for women with conditions that make traditional techniques like Mammograms less effective. The breast cancer diagnostics market is projected to be $2B worldwide and $800M in the U.S. by 2022.
The patents, trademarks and 510 (k) FDA approval would be of interest to medical device/imaging companies, private equity investors among others.
To request bidder credentials or for further information on this auction or other auctions on the Ocean Tomo Bid-Ask™ Market, contact Layna Guo at Layna@OTI.com or 1-312-327-8179.
About the Ocean Tomo Bid-Ask™ Market
The Ocean Tomo Bid-Ask Market is an open on-line platform to buy and sell patents. This market is an important step forward, both as a simplified solution for patent transactions as well as a source of information on patent pricing. The Ocean Tomo Bid-Ask Market uniquely combines the efficiency of an online platform with an experienced team of brokers fluent in both English and Mandarin. The market uses standard transaction documents and is open, transparent and free to view.